Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Ep21: Investing in Prescription DTx

Ep21: Investing in Prescription DTx

FromDTx Podcast with Eugene Borukhovich


Ep21: Investing in Prescription DTx

FromDTx Podcast with Eugene Borukhovich

ratings:
Length:
32 minutes
Released:
May 18, 2021
Format:
Podcast episode

Description

Edward Kliphuis says his love for investing in digital health comes from his love of "playing with toys" and imagining the possible benefit to health outcomes if "damn cool" solutions are scaled significantly. 
M Ventures backs many impressive companies-- like BioLink, Sonde Health, and Akili.
In this episode, Ed talks to Eugene about M Ventures' founding philosophy (how to cut delayed feedback cycles, which M Ventures views as the biggest threat to humanity), approach to investing, and discusses some of the drivers of capital injections in the DTx space. Also, Ed offers his insight into what makes for a truly successful DTx company.

>>Click here to read the transcript

Guest Links and Resources:

Connect with Edward Kliphuis: LinkedIn


Visit Amadeus Capital Partners: Twitter | LinkedIn | Website


Visit M Ventures: LinkedIn | Website



Host Links and Resources:

Connect with Eugene Borukhovich: Twitter | LinkedIn


Follow Eugene's journey of writing his first book: Hard Pill to Swallow


Connect with YourCoach.health: Website | Twitter


Subscribe to Exits & Outcomes


Brian Dolan: Twitter | LinkedIn


HealthXL: Website | Twitter | Join an Event



Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Digital Health Today is made possible by the support of our sponsors. Thank you to:

Bayer G4A

Cedars-Sinai Accelerator

Takeda

Roche
Released:
May 18, 2021
Format:
Podcast episode

Titles in the series (100)

Host Eugene Borukhovich explores how non-molecular therapies and interventions can prevent, manage or even cure diseases. Learn about the rapidly evolving field of Digital Therapeutics, its history, the evolving regulatory and reimbursement frameworks, and the trailblazers creating and advancing this industry.